 |
 |

Association of Serotonin and Cortisol Indices With Childhood Abuse in Bulimia Nervosa
Howard Steiger, PhD;
Lise Gauvin, PhD;
Mimi Israël, MD;
Naomi Koerner, BA;
N. M. K. Ng Ying Kin, PhD;
Joel Paris, MD;
Simon N. Young, PhD
Arch Gen Psychiatry. 2001;58:837-843.
Background Bulimia nervosa (BN) is reported to co-occur with childhood abuse and
alterations in central serotonin (5-hydroxytryptamine [5-HT]) and cortisol
mechanisms. However, findings also link childhood abuse to anomalous 5-HT
and cortisol function, and this motivated us to explore relationships between
childhood abuse and neurobiological variations in BN.
Methods Thirty-five bulimic and 25 nonbulimic women were assessed for childhood
physical and sexual abuse, eating symptoms, and comorbid psychopathological
tendencies. These women provided blood samples for measurement of platelet
hydrogen-3paroxetine binding and serial prolactin and cortisol responses
following oral administration of the partial 5-HT agonist meta-chlorophenylpiperazine (m-CPP).
Results Bulimic women showed markedly lower mean ± SD density (Bmax) of paroxetine-binding sites (631.12 ± 341.58) than did normal
eaters (1213.00 ± 628.74) (t54
= -4.47; P = .001). Paroxetine binding did
not vary with childhood abuse. In contrast, measures of peak change on prolactin
levels after m-CPP administration ( -peak prolactin)
indicated blunted response in abused bulimic women (7.26 ± 7.06), nonabused
bulimic women (5.62 ± 3.95), and abused women who were normal eaters
(5.73 ± 5.19) compared with nonabused women who were normal eaters
(13.57 ± 9.94) (F3,51 = 3.04, P
= .04). Furthermore, individuals reporting childhood abuse showed decreased
plasma cortisol levels relative to nonabused women who were normal eaters.
Conclusion Findings imply that BN and childhood abuse are both generally associated
with reduced 5-HT tone but that childhood abuse may be somewhat more specifically
linked to reduced cortisol levels (ie, hypothalamic-pituitary-adrenal axis)
activity.
From the Eating Disorders Program, Douglas Hospital, Verdun (Drs Steiger
and Israël and Ms Koerner); Department of Psychiatry, McGill University,
Montreal (Drs Steiger, Israël, Ng Ying Kin, Paris, and Young); Research
Centre, Douglas Hospital, Verdun (Drs Israël, Ng Ying Kin, Paris, and
Young); and Department of Social and Preventive Medicine and Groupe de Recherche
Interdisciplinaire en Santé (GRIS), University of Montreal, Montreal
(Dr Gauvin), Quebec.
Corresponding author and reprints: Howard Steiger, PhD, Eating Disorders
Program, Douglas Hospital, 6875 LaSalle Blvd, Verdun, Quebec, Canada H4H 1R3.
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
|